All In Biotech

Drug Trial Radar · NCT07415551

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety and Tolerability of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines (CLEAR)

Last checked: Nov 19, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Mar 26, 2026

Primary completion

Jun 19, 2027

Study completion Jul 24, 2027

Sponsor

Lead sponsor
Yuhan CorporationIndustry
Sponsor type
Industry
First posted
Feb 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to evaluate the efficacy and safety of lesigercept in approximately 150 participants with CSU. By enrolling participants with an inadequate response to H1-antihistamines, including those previously treated with omalizumab, this study is expected to provide evidence for the clinical utility of lesigercept and to further characterize its benefit-risk profile in the target participant population.

Conditions

  • Allergic Diseases
  • Chronic Spontaneous Urticaria (CSU)

Interventions

  • LesigerceptDrug

    Subcutaneous injection of Lesigercept

  • PlaceboDrug

    Subcutaneous injection of None of active ingredient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline Urticaria Activity Score over 7 days (UAS7) at Week 12Time frame: From first dose to Week 12

Locations

30 sites in 4 countries. Site status is shown where the registry gives one.

  • Diagnostic & Consultative Centre Ascendent EOOD

    Sofia, Sofia, Bulgaria · Not yet recruiting

  • UMHAT "Aleksandrovska"

    Sofia, Sofia, Bulgaria · Not yet recruiting

  • Medical Center Hera EOOD

    Sofia, Sofia, Bulgaria · Not yet recruiting

  • UMHATEM "N. I. Pirogov"

    Sofia, Sofia, Bulgaria · Not yet recruiting

  • Dermatology Hospital of Southern Medical University (Guangdong Province Dermatology Hospital)

    Guangzhou, Guangdong, China · Not yet recruiting

  • The University of Hong Kong-Shenzhen Hospital

    Shenzhen, Guangdong, China · Not yet recruiting

  • Alergologia Plus Sp. z o. o.

    Poznan, Greater Poland Voivodeship, Poland · Not yet recruiting

  • Centrum Medyczne ALL-MED

    Krakow, Lesser Poland Voivodeship, Poland · Not yet recruiting

  • Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.

    Krakow, Lesser Poland Voivodeship, Poland · Not yet recruiting

  • Alergo-Med Ośrodek Badań Klinicznych Sp. z o.o.

    Tarnów, Lesser Poland Voivodeship, Poland · Not yet recruiting

  • ALL-MED Specjalistyczna Opieka Medyczna

    Wroclaw, Lower Silesian Voivodeship, Poland · Not yet recruiting

  • DERMACEUM sp. z o.o., DERMACEUM Centrum Medyczne

    Wroclaw, Lower Silesian Voivodeship, Poland · Not yet recruiting

  • Prof. Dorota Krasowska LUXDERM Specjalistyczny Gabinet Dermatologiczny

    Lublin, Lublin Voivodeship, Poland · Not yet recruiting

  • Uniwersytecki Szpital Kliniczny w Opolu

    Opole, Opolskie Voivodeship, Poland · Not yet recruiting

  • Prywatny Gabinet Internistyczno-Alergologiczny Prof. dr hab. Zenon Siergiejko

    Bialystok, Podlaskie Voivodeship, Poland · Not yet recruiting

  • Bio Zdrowie sp. z o.o.

    Bialystok, Podlaskie Voivodeship, Poland · Not yet recruiting

  • NZOZ GynCentrum Oddział Libero

    Katowice, Silesian Voivodeship, Poland · Not yet recruiting

  • Clinic Infertility Treatment Angelius Provita (Centrum Medyczne Angelius Provita)

    Katowice, Silesian Voivodeship, Poland · Not yet recruiting

  • Seoul National University Bundang Hospital

    Gyeonggi-do, Bundang-gu, South Korea · Not yet recruiting

  • Keimyung University Dongsan Hospital

    Daegu, Dalseo-gu, South Korea · Recruiting

  • Korea University Ansan Hospital

    Gyeonggi-do, Danwon-gu, South Korea · Not yet recruiting

  • Chung-Ang University Hospital

    Seoul, Dongjak-gu, South Korea · Recruiting

  • Pusan National University Yangsan Hospital

    Yangsan, Gyeongsangnam-do, South Korea · Not yet recruiting

  • Inha University Hospital

    Incheon, Incheon, South Korea · Not yet recruiting

  • Seoul St. Mary's Hospital, The Catholic University of Korea

    Seoul, Seocho-gu, South Korea · Recruiting

  • Severance Hospital, Yonsei University Health System

    Seoul, Seodaemun-gu, South Korea · Not yet recruiting

  • Kyung Hee University Hospital at Gangdong

    Seoul, Seoul, South Korea · Not yet recruiting

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, Seoul, South Korea · Not yet recruiting

  • Asan Medical Center

    Seoul, Songpa-gu, South Korea · Not yet recruiting

  • Ajou University Hospital

    Gyeonggi-do, Suwon, South Korea · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.